[1]
M. Jayasaputra, F. W. Wagey, and M. R. Rarung, “Mesothelin versus Ca125 in Screening the Ovarian Malignancy”, Indones J Obstet Gynecol, vol. 4, no. 2, pp. 107–110, Apr. 2016.